Significant Transactions (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 07, 2020 |
Jan. 30, 2020 |
Jan. 15, 2020 |
Jun. 30, 2020 |
Jun. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Sep. 01, 2020 |
Jul. 31, 2020 |
Apr. 08, 2020 |
|
Business Acquisition [Line Items] | ||||||||||||
Common stock, shares issued | 1,950,000 | 13,258,707 | 13,258,707 | 19,901,248 | 13,258,707 | 10,589,746 | 800,000 | |||||
Convertible into shares of common stock per share | $ 9.00 | |||||||||||
Percentage of exchange rate | 55.00% | 55.00% | 55.00% | |||||||||
Description of contingent consideration | (i) $0.01 per solo*TAG™ and solo*CODE™ sold or (ii) 7% of net revenue. The fees were to be paid annually until the earlier of: (1) our shares trading above $12 per share for any consecutive 20 trading days in a 30-day period; (b) upon our no longer owning a majority stake in Solo; or (c) upon expiration of the patents related to solo*TAG™ and solo*CODE™, which is December 1, 2029. | |||||||||||
Amortization expense of intangible assets | $ 1,800,000 | $ 1,300,000 | ||||||||||
Revenues | 7,824,784 | $ 6,499,093 | 12,573,276 | $ 10,823,117 | ||||||||
Net loss | $ (16,957,334) | $ (6,090,027) | $ (15,534,345) | $ (12,403,215) | ||||||||
Preferred stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||
Preferred stock, liquidation preference per share | $ 1.00 | |||||||||||
Exchangeable shares | 627,225 | |||||||||||
Exchangeable shares issued | 2,667,349 | 4,798,271 | ||||||||||
Assets and liability acquired | $ 14,300 | |||||||||||
General and administrative expenses | $ 1.8 | 1.1 | ||||||||||
Trellis Solutions, Inc [Member] | ||||||||||||
Business Acquisition [Line Items] | ||||||||||||
Transaction costs | $ 100,000 | |||||||||||
Common stock, shares issued | 349,650 | |||||||||||
Convertible into shares of common stock per share | $ 7.24 | |||||||||||
Percentage of exchange rate | 100.00% | |||||||||||
Amount of contingent consideration liability | $ 1.0 | |||||||||||
Revenues | $ 216,000 | |||||||||||
Net loss | $ 17,000 | |||||||||||
Solo Sciences, Inc. [Member] | ||||||||||||
Business Acquisition [Line Items] | ||||||||||||
Transaction costs | $ 300,000 | |||||||||||
Percentage of exchange rate | 80.40% | 40.00% | 40.00% | 40.00% | ||||||||
Estimated of fair value contingent consideration | $ 17,900,000 | |||||||||||
Revenues | $ 23,000 | |||||||||||
Net loss | $ 1,471,000 | |||||||||||
Ample Organics [Member] | ||||||||||||
Business Acquisition [Line Items] | ||||||||||||
Transaction costs | 2,900,000 | |||||||||||
Revenues | 2.6 | |||||||||||
Net loss | $ 0.1 | |||||||||||
Acquisition of description | acquired 100% of the stock of Ample Organics for 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, $30.7 million was the aggregate value of the exchangeable shares. In addition to the stock consideration, we paid $5.5 million in cash, which was used to settle all of Ample's then outstanding debt. In addition to the stock and cash consideration, the agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. |
X | ||||||||||
- Definition Amount of contingent consideration liability. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquired.. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
X | ||||||||||
- Definition With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. No definition available.
|
X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|